Search filters

List of works by Paola Queirolo

A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.

scientific article published on 5 May 2014

ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion

scientific article published on 11 September 2014

Adoptive Immunotherapy With Tumor-Infiltrating Lymphocytes and Subcutaneous Recombinant Interleukin-2 Plus Interferon Alfa-2a for Melanoma Patients With Nonresectable Distant Disease: A Phase I/II Pilot Trial

scientific article published on 01 April 1999

An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system

scientific article published on 20 December 2018

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies.

scientific article

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab.

scientific article

Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors.

scientific article published on 28 October 2010

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.

scientific article published on 8 March 2017

Biochemotherapy in metastatic melanoma: quo vadis?

scientific article published on 01 October 2005

CDKN2A and MC1R analysis in amelanotic and pigmented melanoma

scientific article published in June 2009

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.

scientific article

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

scientific article

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

scientific article

Clinical genetic testing for familial melanoma in Italy: A cooperative study

article

Combined BRAF and MEK inhibition for the treatment of BRAF-mutated metastatic melanoma.

scientific article published on 29 April 2015

Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.

scientific article

Cytokines can counteract the inhibitory effect of MEK-i on NK-cell function

scientific article published on 22 August 2016

Diagnostic and therapeutic approaches in Italian hospitals: adjuvant and metastatic therapy in melanoma.

scientific article published on 29 May 2013

Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients

scientific article published on 01 December 2004

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma

scientific article

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme

scientific article published on 04 April 2014

Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases

scientific article

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

scientific article published on 25 September 2013

Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study.

scientific article

Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.

scientific article published on 24 March 2011

Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent.

scientific article published on 28 October 2013

Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy.

scientific article published on 30 March 2014

Erratum to: Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

scholarly article published in Cancer Immunology, Immunotherapy

Erythropoietin and granulocyte-macrophage colony-stimulating factor allow acceleration and dose escalation of cyclophosphamide/epidoxorubicin/5-fluorouracil chemotherapy: a dose-finding study in patients with advanced breast cancer.

scientific article

INK4/ARF germline alterations in pancreatic cancer patients.

scientific article

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma

article

Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in Italian melanoma families displaying pancreatic cancer and neuroblastoma

article

Inherited variants in the MC1R gene and survival from cutaneous melanoma: a BioGenoMEL study

scientific article

Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferon

scientific article published on 19 December 2013

Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial

scientific article

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

scientific article

Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy

scientific article published on 11 March 2014

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in <i>BRAF</i>-mutant melanoma

scientific article published on 01 December 2020

MC1Rvariation and melanoma risk in relation to host/clinical and environmental factors inCDKN2Apositive and negative melanoma patients

article

Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression

scientific article

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor.

scientific article published on 25 May 2012

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma

scientific article published on 9 February 2006

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

scientific article published in February 2016

Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer

scientific article published on 27 June 2012

Open-label, multicentre safety study of vemurafenib in 3219 patients with BRAFV600 mutation-positive metastatic melanoma: 2-year follow-up data and long-term responders' analysis.

scientific article

Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancer

scientific article published on 01 January 1997

Potential Role of Soluble c-Met as a New Candidate Biomarker of Metastatic Uveal Melanoma

scientific article published on 11 June 2015

Predictive role of preoperative lymphoscintigraphy on the status of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma.

scientific article published in August 2009

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.

scientific article published on 10 December 2012

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma

scientific article

Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.

scientific article published on March 2004

Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program

scientific article

Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.

scientific article published on 5 March 2010

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.

scientific article published on 28 March 2009

Sun exposure and melanoma prognostic factors

scientific article published on March 2016

Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review.

scientific article published on 08 March 2016

Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells

scientific article

Targeted therapies in melanoma.

scientific article published on 27 September 2006

Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5-7, 2012.

scientific article

The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

scientific article published on 18 November 2015

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.

scientific article published on 12 February 2008

The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production

scientific article published on May 2013

The prognostic role of the sentinel lymph node in clinically node-negative patients with cutaneous melanoma: experience of the Genoa group

scientific article published in December 2005

The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival.

scientific article published in February 2014

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study

scientific article published on 23 December 2014

Thymidine labeling index analysis in early breast cancer patients randomized to receive perioperative chemotherapy

scientific article

Treatment of metastatic uveal melanoma with intravenous fotemustine

scientific article

Upcoming strategies for the treatment of metastatic melanoma.

scientific article published on 17 February 2012

Update on Metastatic Uveal Melanoma: Progress and Challenges.

scientific article published on 21 March 2016

Update: current management issues in malignant melanoma.

scientific article

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

scientific article published on 01 October 2002

Vemurafenib in BRAFV600 mutated metastatic melanoma: a subanalysis of the Italian population of a global safety study.

scientific article published on January 2015

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

scientific article

Paulina is supported by:

About Paulina

Help